WNT4 and neoplasm: According to our findings, we propose a model wherein after BRCA1 function is downregulated or inactivated by gene mutations or epigenetic silencing (e.g. DNA methylation), oncogenic NEAT1 is upregulated to epigenetically downregulate tumor-suppressive miR-129-5p expression and subsequently activate WNT4 expression.